Post hoc analysis of the glutamics–trial: intravenous glutamate infusion and use of inotropic drugs after cabg

BACKGROUND: Intravenous glutamate reduced the risk of developing severe circulatory failure after isolated coronary artery bypass graft surgery (CABG) for acute coronary syndrome (ACS) in a double-blind randomised clinical trial (GLUTAMICS-ClinicalTrials.gov Identifier:NCT00489827). Here our aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidlund, Mårten, Tajik, Bashir, Håkanson, Erik, Friberg, Örjan, Holm, Jonas, Vanky, Farkas, Svedjeholm, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971701/
https://www.ncbi.nlm.nih.gov/pubmed/27484576
http://dx.doi.org/10.1186/s12871-016-0216-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971701/
https://www.ncbi.nlm.nih.gov/pubmed/27484576
http://dx.doi.org/10.1186/s12871-016-0216-z

Ejemplares similares